East and North Herts NHS Trust, Hertfordshire, UK.
University of Glasgow, Glasgow, UK.
BMC Nephrol. 2024 Jul 6;25(1):216. doi: 10.1186/s12882-024-03664-1.
The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.
慢性肾脏病（CKD）合并 1 型或 2 型糖尿病会显著增加心血管疾病（CVD）的发病风险。血脂是一个可改变的危险因素，良好的血脂管理可以改善糖尿病肾病（DKD）患者的预后。本指南由英国临床糖尿病学家协会（ABCD）和英国肾脏病协会（UKKA）工作组撰写，主要目的是为多学科团队成员提供有关 DKD 成人血脂管理的实用建议。
Br Med Bull. 2018-3-1
Am J Kidney Dis. 2014-10
JBI Database System Rev Implement Rep. 2016-7
Int J Nanomedicine. 2025-5-24
Electrolyte Blood Press. 2024-12
Int J Mol Sci. 2024-9-23
N Engl J Med. 2023-4-13
Eur Heart J. 2023-1-7
N Engl J Med. 2020-4-16
N Engl J Med. 2020-3-18
Zotero 插件